(Q41507251)

1 October 2017

Distribution of 4'epi-doxorubicin in human tissues (English)

1 reference

1 October 2017

Italia C

1

1 reference

1 October 2017

Paglia L

2

1 reference

1 October 2017

Trabattoni A

3

1 reference

1 October 2017

Luchini S

4

1 reference

1 October 2017

Villas F

5

1 reference

1 October 2017

Beretta L

6

1 reference

1 October 2017

Marelli G

7

1 reference

1 October 2017

Natale N

8

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 April 1983

1 reference

British Journal of Cancer

1 October 2017

1 reference

1 October 2017

47

1 reference

1 October 2017

4

1 reference

1 October 2017

545-547

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1983.86

1 October 2017

0 references

cites work

Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011320

Preliminary phase I study of 4'-epi-adriamycin

10 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2011320

Plasma and urinary levels of adriamycin in man

10 June 2018

1 reference

12 December 2020

Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function

1 reference

12 December 2020

Studies on the comparative distribution and biliary excretion of doxorubicin and 4'-epi-doxorubicin in mice and rats

1 reference

12 December 2020

In vitro uptake and cytotoxicity of adriamycin in primary and metastatic lewis lung carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1983.86

1 reference

1 October 2017

1 reference

1 October 2017

PubMed publication ID

6573906

1 reference